Open Journal of Respiratory Diseases
Vol.7 No.4(2017), Paper ID 79633, 11
pages
DOI:10.4236/ojrd.2017.74013
A Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Study on ColdZyme® Mouth Spray against Rhinovirus-Induced Common Cold
Mats Clarsund, Marcus Fornbacke, Lena Uller, Sebastian L. Johnston, Cecilia Ahlström Emanuelsson
Enzymatica AB, Lund, Sweden
Enzymatica AB, Lund, Sweden
Unit of Respiratory Immunopharmacology, Department of Experimental Medical Science, Lund University, Lund, Sweden
Airway Disease Infection Section, National Heart and Lung Institute, Imperial College, London, UK
Department of Otorhinolaryngology, Skåne University Hospital, Lund, Sweden
Copyright © 2017 Mats Clarsund, Marcus Fornbacke, Lena Uller, Sebastian L. Johnston, Cecilia Ahlström Emanuelsson et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Clarsund, M. , Fornbacke, M. , Uller, L. , Johnston, S. and Emanuelsson, C. (2017) A Randomized, Double-Blind, Placebo-Controlled Pilot Clinical Study on ColdZyme
® Mouth Spray against Rhinovirus-Induced Common Cold.
Open Journal of Respiratory Diseases,
7, 125-135. doi:
10.4236/ojrd.2017.74013.